Blog Post USD/JPY Sell-off Amid BOJ Announcement What Happened Yesterday There was some profit-taking and selling in USD/JPY yesterday despite a higher move in Treasury yields. I would attribute that to fears ahead of the BOJ today, just in case the Japanese central bank produced a more hawkish message. But alas, they didn’t deliver on…
Global Flavors Meet Local Ingredients and Fuel the Food Service Industry’s Future, with a projected US$ 5,704,966.8 million Value by 2033 North America Leading the Way Between 2023 and 2033, North America is expected to lead the food service solutions industry, with rising restaurant expenses in countries like the US and Canada. NEWARK, Del, Sept….
Former President’s Dangerous Military Impulses Restraining Trump’s Provocative Actions In a recent article published by The Atlantic, it was revealed that former President Donald Trump dismissed the threat of North Korean dictator Kim Jong Un targeting Guam with nuclear weapons by claiming that “Guam isn’t America.” This disturbing incident sheds light on the reckless behavior…
ArticleIFY Nacho Believes Bellingham is the Future of Real Madrid Nacho’s Bold Prediction After witnessing Jude Bellingham’s impressive performance in the Champions League match against Union Berlin, Real Madrid’s Nacho made a bold declaration that sent shockwaves through the football world. The young midfielder’s sixth goal in six games caught the eye of many, including…
The Impact of Class Action Lawsuits on Investors Understanding the Deadline for Filing a Lead Plaintiff Motion Investors Beware: Time is Running Out As the deadline approaches for filing a lead plaintiff motion in the class action lawsuit against Leslie’s, Inc., investors need to be aware of the potential impact on their investments. Glancy Prongay…
FDA Grants Orphan Drug Designation to Immix Biopharma’s NXC-201 for AL Amyloidosis Treatment: A Victory for Patients The News We’ve Been Waiting For It’s official – the U.S. Food and Drug Administration has granted Orphan Drug Designation to Immix Biopharma’s NXC-201 for the treatment of Amyloid Light Chain (AL) Amyloidosis. This is a major victory…
Innovative IP Solutions for Robotics and AR/VR/MR Applications VeriSilicon and Inuitive Collaboration SHANGHAI–(BUSINESS WIRE)–November 12, 2021– VeriSilicon, a leading provider of silicon intellectual property (IP) solutions, has recently announced a collaboration with Inuitive, a prominent vision-on-chip processor company. Inuitive has integrated VeriSilicon’s dual-channel Image Signal Processor (ISP) IP into its mass-produced NU4100 vision AI processor,…
Chardan Engaged to Facilitate Nocturne Acquisition Corporation’s Business Combination with Cognos Therapeutics WILMINGTON, Del. and INGLEWOOD, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) Nocturne Acquisition Corporation (NASDAQ:MBTC, MBTCU, MBTCR) (“Nocturne”) and Cognos Therapeutics, Inc. (“Cognos”) have made a significant announcement today with the engagement of Chardan, a leading global investment bank, in the role of capital…
